Carbetapentane tannate 12 mg/mL / chlorpheniramine tannate 1.6 mg/mL / phenylephrine tannate 4 mg/mL Oral Suspension
RxNorm 1249050
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1249050 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: carbetapentane tannate 12 mg/mL / chlorpheniramine tannate 1.6 mg/mL / phenylephrine tannate 4 mg/mL Oral Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Carbetapentane tannate 12 mg/ML / chlorpheniramine tannate 1.6 mg/ML / phenylephrine tannate 4 mg/ML Oral Suspension
(Atom ID: 12345342)
PSN
Prescribable Name (PSN):
Carbetapentane tannate 12 mg/mL / chlorpheniramine tannate 1.6 mg/mL / phenylephrine tannate 4 mg/mL Oral Suspension
(Atom ID: 12518321)
SY